SDS Biotech K.K. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017
SDS Biotech K.K. reported consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of ¥2,165 million against ¥4,229 million a year ago. Operating income was ¥448 million against ¥531 million a year ago. Ordinary income was ¥608 million against ¥458 million a year ago. Net income attributable to owners of parent was ¥335 million or ¥42.84 per basic share against ¥320 million or ¥40.92 per basic and diluted share a year ago. Net loss before taxes was ¥607,967,000.
For the fiscal year ending March 31, 2017, the company expects net sales of ¥16,210 million, operating income of ¥1,460 million, ordinary income of ¥1,220 million and net income of ¥820 million or ¥104.71 per share.